Concentriq is Designed for Research and Clinical workflows.
Concentriq, our AI-powered software platform sits at the intersection of digital and computational pathology, where functionality needed to carry out routine pathology operations connects with powerful AI applications to accelerate breakthroughs and improve patient outcomes.
Powering primary diagnostic workflows to drive efficiency and improve quality.
Centralizing and unifying data-centric research from discovery to market.
AI-powered pathology for the modern laboratory
Concentriq delivers access to the broadest portfolio of computational applications, fully integrated into routine workflows.
Introducing Automated Quality Control for Concentriq, our AI-enabled application for performing QC on images.
Unlock groundbreaking insights and speed research from discovery to market.
10 of the top 20 pharma leaders run our Concentriq digital pathology platform to unify multi-site teams, data, and applications, and drive image-based research at scale.
Webinar: Building a Broader Research Ecosystem
Scientists at Bristol Myers Squibb are at the forefront of spatial transcriptomics and computational pathology. Find out how they are utilizing a centralized platform for pathology images, metadata, and analysis results.
Navigate your digital journey with confidence.
Whether you’re just getting started with digital pathology, or ready to take advantage of AI-powered workflows, Proscia can help guide you forward.
The Digital Pathology Transformation Playbook
We’ll help you shape a strategic plan for adopting and integrating digital pathology into your practice through a software-led approach. The Playbook will show you how.
We believe that pathology deserves great technology.
We’re helping labs and research centers take advantage of the collaboration, insight, accuracy and time-saving benefits of digital pathology, and accelerating breakthroughs in the fight against cancer. Learn more about our vision for powering this new era of data-driven pathology.
Latest Resources
Latest Resources
Press Release
Proscia Secures $37M Series C investment to help fulfill the promise of precision medicine with AI-enabled pathology.
Blog
Presenting On Automated Quality Control At The European Congress On Digital Pathology (ECDP)